HOMEVULNERABILITIESCVE-2026-35250
LOW

CVE-2026-35250

Published: April 21, 2026· Updated: Apr 23, 2026

2.3
CVSS v3.1
EPSS:0.01%probability of exploitation in 30 daysPercentile:1.5th

Official Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.6. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. Successful attacks of this vulnerability can result in unauthorized ability to cause a partial denial of service (partial DOS) of Oracle VM VirtualBox. CVSS 3.1 Base Score 2.3 (Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:L).

NVD Source

Technical Analysis

CVE-2026-35250 requires local access, meaning attackers must already have a foothold on the target system.

Exploitation requires high privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorLocal
Attack ComplexityLow
Privileges Req.High
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityNone
IntegrityNone
AvailabilityLow
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:L

Affected Vendors & Products

Oracle1 product
vm virtualbox
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (1)

Quick Facts

CVE IDCVE-2026-35250
CVSS Score2.3 / 10
SeverityLOW
CISA KEVNo
EPSS (30d)0.01%
Affected1 vendor
PublishedApr 21, 2026

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-35250 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.